Chris Houchens | Director, Division CBRN MCMs
BARDA

Pre-Congress Workshops - 21st April @ 10:00

ANTIMICROBIAL RESISTANCE

Pipeline Updates for Priority Pathogens

10am Chair’s opening remarks

10:15 WHO updated priority pathogens

10:30 Vaccines against Salmonella and Shigella enteric pathogensFrancesca Micoli, Director, GVGH Innovation Academy & Senior Project Leader, GSK

11:00 Oligosaccharide synthesis for vaccine development against Acinetobacter Prof Luigi Lay, Department of Chemistry, University of Milan

11:15 A Maternally Administered Vaccine for Infant Group B StreptococcusSenior Representative, Pfizer   

11:30 Vaccine Development against Staph Aures

11:45 A vaccine against staph and MRSA infectionsProf Xufei Huang, Associate Chair for Research, Chemistry and Biomedical Engineering, Michigan State University

12:00 Vaccine development against KlebsiellaTim Cooke, CEO, Omniose

12:15 Panel: Commonalities and challenges for advancing the development of vaccines against priority AMR pathogensAll Morning Speakers 

1:00 - 2:00 Lunch Break 

2:00 Panel: Development and impact of novel TB vaccines

3:00 TBC

3:30 BMGF AMR Strategy Dr Usman Nakakana, Senior Progam Officer for Clinical Vaccine Development, BMGF 

4:00 Panel: Funding and Partnering to support novel tools against AMRDr Usman Nakakana, Senior Progam Officer for Clinical Vaccine Development, BMGF Chris Houchens, Director Division of CBRN Countermeasures, BARDA

Chris Houchens, Director, Division CBRN MCMs, BARDA

Usman Nakakana, Senior Program officer vaccine development and impact, Bill and Melinda Gates Foundation

Tim Cooke, CEO, Omniose

Xufei Huang, MSU Research Foundation Professor, Associate Chair for Research, Chemistry and Biomedical Engineering, Michigan State University

Luigi Lay, Lecturer -Department of Chemistry, University of MILAN

×

Luigi Lay / ANTIMICROBIAL RESISTANCE

Luigi Lay, Lecturer -Department of Chemistry,
University of MILAN

Luigi Lay graduated in Chemistry in 1990 and was awarded a PhD in Chemical Sciences in 1994 at the University of Milan, working on the synthesis of Streptococcus pneumoniae capsular polysaccharide fragments. After an EU-funded post-doctoral fellowship in the research group of Prof. Richard...

CloseMore

Francesca Micoli, Director GVGH Innovation Academy and Senior Project Leader, GVGH